Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by toinv261on Jul 08, 2014 10:18am
197 Views
Post# 22724642

RE:RE:RE:RE:DO BLOOD LEVELS OF APOA-1 REALLY MATTER SO MUCH????

RE:RE:RE:RE:DO BLOOD LEVELS OF APOA-1 REALLY MATTER SO MUCH????Thanks beardownz for the clear explanation, much appreciated.

The fact that it takes people like you on these posts to figure out what rvx-208 actually does and how it works is one of the big reasons why the RVX share price is so undervalued. Average investors are confused by the complexity of scientific jargon and the hard work it takes to filter through the scientific jargon. Although we have the transcripts from the webcasts very few average investors are going to review these 30+ page documents and try to figure  out what they say.

RVX should be able to explain the following in simple layman's terms;
  1. What do the broad scientific research fiindings say that support the underlying strategy that rvx-208 is built on? (e.g. BET inhibitors, etc)
  2. What does rvx-208 do based on the available research? (in simple terms)
  3. What do we know and what do we not know?
  4. Does/could rvx-208 work on it's own?
  5. Why is it worth continuing rvx-208 research to ph2c?

Those are the most basic questions and not a complete list but you get the idea...the KISS principle.


From a retail investor perspective this would allow RVX to appeal to a broader base of investors.

From my perspective I'm counting on the scientific brains at NGN, Eastern and RVX to have done their homework. Since they are putting in their money I'm sure they are totally convinced about the future potential of rvx-208.

Cheers
Toinv

Bullboard Posts